Vida Ventures Advisors, LLC

In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 3, 2025), Vida Ventures Advisors, LLC reported 2 stock positions worth $29.4 million. Its top holding was Kyverna Therapeutics (KYTX) at 92.4% of the portfolio, followed by Allogene Therapeutics (ALLO, 7.6%). Its holdings were unchanged from Q2 2025.

Most Recent 13F
Q3 2025
Location
BOSTON, MA
CIK
0001831423
Portfolio Value
$29.4M (Q3 2025)
SEC Filing
0001172661-25-004558 ↗ filed Nov 3, 2025

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $180.0M Q1 2024 Q2 2024: $91.4M Q2 2024 Q3 2024: $138.6M Q3 2024 Q4 2024: $146.3M Q4 2024 Q1 2025: $13.6M Q1 2025 Q2 2025: $15.9M Q2 2025 Q3 2025: $29.4M $29.4M Q3 2025

Holdings 2 stocks · $29.4M
KYTX Kyverna Therapeutics Inc. 92.41% 4,523,924 $27.1M No change
ALLO Allogene Therapeutics Inc. 7.59% 1,798,163 $2.2M No change

Portfolio Sells Q2 2025 → Q3 2025
None this quarter.

Portfolio Buys Q2 2025 → Q3 2025
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q3 2025 2$29.4MKYTX, ALLO
Q2 2025 2$15.9MKYTX, ALLO
Q1 2025 3$13.6MKYTX, ALLO, KRON
Q4 2024 6$146.3MCNTA, TECX, KYTX, DYN, ALLO
Q3 2024 6$138.6MCNTA, TECX, KYTX, DYN, ALLO
Q2 2024 5$91.4MCNTA, KYTX, DYN, ALLO, KRON
Q1 2024 5$180.0MKYTX, CNTA, DYN, ALLO, KRON